Open Access

Novel strategies to lower Lp(a) What are the emerging insights & therapies?

Topic: Lipids
Organised by PACE-CME, supported by Novartis and Sanofi in the form of an educational grant

Congress Presentation

About the speaker

Professor Sotirios Tsimikas

University of California San Diego, San Diego (United States of America)
6 presentations
0 follower

4 more presentations in this session

Lp(a): The new kid in lipid management

Speaker: Professor E. Stroes (Amsterdam, NL)


Lp(a) as target in cardiovascular prevention: Why worry and how to assess?

Speaker: Professor P. Kamstrup (Herlev, DK)


ASCVD risk reduction for patients with high Lp(a) in 2020: is there a role for PCSK9 inhibition?

Speaker: Professor V. Bittner (Birmingham, US)



Speaker: Professor E. Stroes (Amsterdam, NL)


Access the full session

Lp(a), a new lipid frontier in CV risk management & target for therapy

Speakers: Professor S. Tsimikas, Professor E. Stroes, Professor P. Kamstrup, Professor V. Bittner, Professor E. Stroes

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb